Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage

Breast Journal

Volumn 13, Issue 3, 2007, Pages 281-286

  Ghanouni, Pejman ^a   Kurian, Allison W ^a   Margolis, Daniel ^a   Hartman, Anne Renee ^b   Mills, Meredith A ^a   Plevritis, Sylvia K ^a   Ford, James M ^a   Daniel, Bruce L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Alta Bates Medical Center   (United States)

Author keywords

BRCA1 2; Breast cancer; Breast magnetic resonance imaging; Ductal carcinoma in situ; Ductal lavage; Screening

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; BREAST DUCT; CANCER CHEMOTHERAPY; CANCER SCREENING; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; SALPINGOOOPHORECTOMY;

ADULT; BREAST; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOLOGY, INTERVENTIONAL; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 34247477546     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00422.x     Document Type: Article

References (22)

1. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003 72 : 1117 30.
2. Liberman L. Breast cancer screening with MRI - what are the data for patients at high risk? N Engl J Med 2004 351 : 497 500.
3. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004 22 : 1055 62.
4. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002 225 : 165 75.
5. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004 351 : 427 37.
6. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000 92 : 1217 27.
7. Hartman AR, Daniel BL, Kurian AW, et al. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer 2004 100 : 479 89.
8. Higgins S, Matloff E, Rimm D, Dziura J, Haffty B, King B. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Breast Cancer Res 2005 7 : R1017 22.
9. Mitchell G, Antill YC, Murray W, et al. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res 2005 7 : R1122 31.
10. Kurian AW, Mills MA, Jaffee M, et al. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005 14 : 1082 89.
11. Agoston AT, Daniel BL, Herfkens RJ, et al. Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data. Radiographics 2001 21 : 217 26.
12. Yen YF, Han KF, Daniel BL, et al. Dynamic breast MRI with spiral trajectories: 3D versus 2D. J Magn Reson Imaging 2000 11 : 351 59.
13. Leong CS, Daniel BL, Herfkens RJ, et al. Characterization of breast lesion morphology with delayed 3DSSMT: an adjunct to dynamic breast MRI. J Magn Reson Imaging 2000 11 : 87 96.
14. Ikeda DM, Hylton NM, Kinkel K, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001 13 : 889 95.
15. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004 292 : 1317 25.
16. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005 365 : 1769 78.
17. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005 23 : 8469 76.
18. Blue Cross Blue Shield Technology Evaluation Center. Magnetic Resonance Imaging of the Breast in Screening Women Considered to be at High Genetic Risk of Breast Cancer. http://www.bcbs.com/tec/vols/19/19_01.html
19. National Comprehensive Cancer Network. Breast Cancer Treatment Guidelines 2006. http://www.nccn.org/professionals/physician_gls/PDF-breast.pdf
20. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol 2003 181 : 519 25.
21. Love S, Barsky SH. Anatomy of the nipple and breast ducts revisited. Cancer 2004 101 : 1947 57.
22. Zalles C, Kimler B, Simonsen M, Clark J, Metheny T, Fabian C. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 2006 97 : 191 7.